DTIL
PRECISION BIOSCIENCES INC
PRECISION BIOSCIENCES INC (DTIL) has 9 SEC Form 4 filings (13 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: May 22, 2026.
Insiders have net sold $148K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Juli Blanche
- Employees:108
- HQ:Durham, NC, US
- IPO:2019-03-28
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$148K
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$191.5M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
SMITH J. JEFFERSONFirst filing | Chief Research Officer | Sale | 4,925 | $19K | Feb 19 | SEC ↗ |
Amoroso MichaelFirst filing | President and CEO | Sale | 20,559 | $79K | Feb 19 | SEC ↗ |
Kelly John AlexanderFirst filing | Chief Financial Officer | Sale | 8,149 | $31K | Feb 19 | SEC ↗ |
Scimeca DarioFirst filing | General Counsel and Secretary | Sale | 4,925 | $19K | Feb 19 | SEC ↗ |
Related companies
PRECISION BIOSCIENCES INC is in the Healthcare sector.